Idioma:

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

LJUNGMAN, P ; BREGNI, M ; PETERS, C ; ROCHA, V ; SACCARDI, R ; SCHOUTEN, H ; SUREDA, A ; TICHELLI, A ; VELARDI, A ; NIEDERWIESER, D ; BRUNE, M ; CORNELISSEN, J ; DE WITTE, T ; DINI, G ; EINSELE, H ; GASPAR, H. B ; GRATWOHL, A ; PASSWEG, J

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.219-234 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por

Enviar para

Título:
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
Autor: LJUNGMAN, P ; BREGNI, M ; PETERS, C ; ROCHA, V ; SACCARDI, R ; SCHOUTEN, H ; SUREDA, A ; TICHELLI, A ; VELARDI, A ; NIEDERWIESER, D ; BRUNE, M ; CORNELISSEN, J ; DE WITTE, T ; DINI, G ; EINSELE, H ; GASPAR, H. B ; GRATWOHL, A ; PASSWEG, J
Assuntos: Adolescent ; Adult ; Aged ; Amyloidosis ; Amyloidosis - therapy ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Autografts ; Autoimmune diseases ; Biological and medical sciences ; Blood ; Blood diseases ; Bone Marrow Transplantation ; Bone marrow, stem cells transplantation. Graft versus host reaction ; Care and treatment ; Child ; Clinical Protocols ; Cord blood ; Europe ; Health aspects ; Hematologic Diseases - therapy ; Hematological diseases ; Hematology ; Hematopoietic Stem Cell Transplantation ; Hematopoietic stem cells ; Hodgkin Disease - therapy ; Humans ; Imatinib ; Immune System Diseases - therapy ; Infant ; Leukemia - therapy ; Lymphoma ; Lymphoma, Non-Hodgkin - therapy ; Medical sciences ; Medicin och hälsovetenskap ; Middle Aged ; Multiple tumors. Solid tumors. Tumors in childhood (general aspects) ; Myeloproliferative Disorders - therapy ; Neoplasms - therapy ; Peripheral blood ; Severe Combined Immunodeficiency - therapy ; Solid tumors ; Stem cell transplantation ; Stem cells ; Subgroups ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Transplantation ; Transplantation Conditioning ; Transplantation, Autologous ; Transplantation, Homologous ; Transplants ; Transplants & implants ; Tumors
É parte de: Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.219-234
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: The European Group for Blood and Marrow Transplantation regularly publishes special reports on the current practice of haematopoietic SCT for haematological diseases, solid tumours and immune disorders in Europe. Major changes have occurred since the first report was published. HSCT today includes grafting with allogeneic and autologous stem cells derived from BM, peripheral blood and cord blood. With reduced-intensity conditioning regimens in allogeneic transplantation, the age limit has increased, permitting the inclusion of older patients. New indications have emerged, such as autoimmune disorders and AL amyloidosis for autologous HSCT and solid tumours, myeloproliferative syndromes and specific subgroups of lymphomas for allogeneic transplants. The introduction of alternative therapies, such as imatinib for CML, has challenged well-established indications. An updated report with revised tables and operating definitions is presented.
Editor: Basingstoke: Nature Publishing Group
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

LJUNGMAN, P ; BREGNI, M ; PETERS, C ; ROCHA, V ; SACCARDI, R ; SCHOUTEN, H ; SUREDA, A ; TICHELLI, A ; VELARDI, A ; NIEDERWIESER, D ; BRUNE, M ; CORNELISSEN, J ; DE WITTE, T ; DINI, G ; EINSELE, H ; GASPAR, H. B ; GRATWOHL, A ; PASSWEG, J

Basingstoke: Nature Publishing Group

Buscando em bases de dados remotas. Favor aguardar.